Baccari M C, Calamai F, Staderini G
Department of Physiology, University of Florence, Italy.
Gastroenterology. 1996 Jan;110(1):129-38. doi: 10.1053/gast.1996.v110.pm8536849.
BACKGROUND & AIMS: Prostaglandin (PG) E2 has been shown to modulate adrenergic and cholinergic neurotransmission in the gut. This study investigated PGE2 influence on vagally induced, nonadrenergic, noncholinergic (NANC) gastric relaxations.
Mechanical activity of the stomach was recorded in anesthetized rabbits.
In atropine-treated animals, electrical vagal stimulation or arterial bolus injection of the ganglion stimulant dimethyl phenylpiperazinium iodide (DMPP) evoked inhibitory responses that varied from a brisk relaxation, interrupted by a poststimulus excitatory motility (biphasic response), to a long-lasting relaxation (monophasic response). PGE2 reduced and, at the highest doses, abolished the neurally induced relaxant responses elicited either by vagal stimulation or DMPP administration but did not affect the gastric relaxation caused by adenosine triphosphate (ATP), sodium nitroprusside (SNP), or vasoactive intestinal polypeptide (VIP). ATP or 2-methylthioadenosine triphosphate (2-MeSATP) reduced and then suppressed vagally induced inhibitory motility; the relaxant responses elicited by SNP, VIP, and ATP itself were not influenced. After administration of the prostaglandin synthesis inhibitor suprofen, ATP and 2-MeSATP failed to block vagally induced inhibitory responses. Arterial infusion of adenosine at the highest rates did not influence the amplitude of the vagally induced relaxant responses. Following theophylline administration, ATP still blocked the relaxation elicited by vagal stimulation.
PGE2 may modulate NANC inhibitory neurotransmission in the stomach. The effects of ATP on the neurally induced NANC gastric relaxation may be caused by PGE2.
前列腺素(PG)E2已被证明可调节肠道中的肾上腺素能和胆碱能神经传递。本研究调查了PGE2对迷走神经诱导的非肾上腺素能、非胆碱能(NANC)胃舒张的影响。
在麻醉的兔子身上记录胃的机械活动。
在阿托品处理的动物中,迷走神经电刺激或动脉推注神经节兴奋剂碘化二甲基苯基哌嗪(DMPP)可诱发抑制反应,反应从快速舒张(被刺激后兴奋性运动打断,双相反应)到持久舒张(单相反应)不等。PGE2降低并在最高剂量时消除了迷走神经刺激或DMPP给药引起的神经诱导舒张反应,但不影响三磷酸腺苷(ATP)、硝普钠(SNP)或血管活性肠肽(VIP)引起的胃舒张。ATP或2-甲硫基三磷酸腺苷(2-MeSATP)先降低然后抑制迷走神经诱导的抑制性运动;SNP、VIP和ATP本身引起的舒张反应不受影响。给予前列腺素合成抑制剂舒洛芬后,ATP和2-MeSATP未能阻断迷走神经诱导的抑制反应。以最高速率动脉输注腺苷不影响迷走神经诱导的舒张反应幅度。给予茶碱后,ATP仍能阻断迷走神经刺激引起的舒张。
PGE2可能调节胃中的NANC抑制性神经传递。ATP对神经诱导的NANC胃舒张的作用可能由PGE2引起。